Effect of whole-body cryotherapy treatments on the functional state of patients with MS (multiple sclerosis) in a Timed 25-Foot Walk Test and Hand Grip Strength Test

Anna Lubkowska, Aleksandra Radecka, Anna Knyszyńska, Joanna Łuczak

Abstract


Introduction: Whole-body cryotherapy (WBC) is one of the main elements of comprehensive rehabilitation of patients with multiple sclerosis (MS). It is used both to improve the mental and physical condition of patients.

The study attempts to assess the effect of a series of 20 daily WBC treatments on global walking function and muscle strength in patients with MS.

Materials and methods: The study included 25 patients with diagnosed MS (ICD10-G35), mean age 44.58 ±12.15 years, who after a detailed medical examination were qualified to a series of 20 daily WBC treatments. Treatments lasted 2–3 min at -110°C. Before and after the series of WBC treatments, all subjects were tested for global hand grip and thumb strength using a hydraulic dynamometer (kg) for both the right and the left hands, as well as measuring the time needed to walk a distance of 7.6 metres, in accordance with the Timed 25-Foot Walk Test, a standardised diagnostic test recommended for the global assessment of walking function by the National Multiple Sclerosis Society. The obtained results were subjected to statistical analysis.

Results: After the series of WBC treatments, a marginal but statistically significant increase in thumb strength was observed in the right hand (p < 0.01). Other changes in the value of handgrip and thumb strength were not statistically significant. In addition, there were no statistically significant changes in the average time needed to cover the walking distance of 7.6 metres.

Conclusions: The series of 20 daily WBC treatments for patients with MS did not significantly improve global walking function, although a beneficial effect on the thumb strength of the right hand was observed.


Keywords


multiple sclerosis; whole-body cryotherapy; Timed 25-Foot Walk; Hand Grip Strength Test

Full Text:

PDF

References


Sutliff MH. Contribution of impaired mobility to patient burden in multiple sclerosis. Curr Med Res Opin 2010;26(1):109-19.

Mickiewicz P, Garczyński W. Możliwości funkcjonalne chorych na stwardnienie rozsiane w zależności od czasu trwania choroby. J Education Health Sport 2016;6(9):757-71.

Panitch H, Applebee A. Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disability. Expert Opin Pharmacother 2011;12(10):1511-21.

Polman CH, Rudick RA. The multiple sclerosis functional composite: a clinically meaningful measure of disability. Neurology 2010;74 Suppl 3:S8-15.

Ontaneda D, LaRocca N, Coetzee T, Rudick R. Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures. Mult Scler 2012;18(8):1074-80.

Goodman AD, Brown TR, Cohen JA, Krupp LB, Schapiro R, Schwid SR, et al. Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology 2008;71(15):1134-41.

Johansson S, Ytterberg C, Claesson IM, Lindberg J, Hillert J, Andersson M, et al. High concurrent presence of disability in multiple sclerosis. Associations with perceived health. J Neurol 2007;254(6):767-73.

Kierkegaard M, Einarsson U, Gottberg K, von Koch L, Holmqvist LW. The relationship between walking, manual dexterity, cognition and activity/participation in persons with multiple sclerosis. Mult Scler 2012;18(5):639-46.

Severijns D, Lamers I, Kerkhofs L, Feys P. Hand grip fatigability in persons with multiple sclerosis according to hand dominance and disease progression. J Rehabil Med 2015;47(2):154-60.

Lubkowska A. Zastosowanie krioterapii w chorobach przewlekłych. Fam Med Primary Care Rev 2013;15(2):233-9.

Miller E, Kostka J, Włodarczyk T, Dugué B. Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study. Acta Neurol Scand 2016;134(6):420-6. doi: 10.1111/ane.12557.

Miller E, Mrowicka M, Malinowska K, Mrowicki J, Saluk-Juszczak J, Kędziora J. The effects of whole-body cryotherapy on oxidative stress in multiple sclerosis patients. J Therm Biol Psychiatry 2010;35(8):406-10.

Miller E, Mrowicka M, Malinowska K, Żołyński K, Kędziora J. Effects of whole-body cryotherapy on total antioxidative status and activities of some antioxidative enzymes in blood of patients with multiple sclerosis – preliminary study. J Med Invest 2010;57(1-2):168-73.

Miller E, Markiewicz Ł, Saluk J, Majsterek I. Effects of short-term cryostimulation on antioxidative status and its clinical applications in humans. Eur J Appl Physiol 2012;112(5):1645-52.

Miller E, Mrowicka M, Malinowska K, Mrowicki J, Saluk-Juszczak J, Kędziora J. Effects of whole body cryotherapy on a total antioxidative status and activities of antioxidant enzymes in blood of depressive multiple sclerosis patients. World J Biol Psychiatry 2011;12(3):223-7.

Miller E, Saluk J, Morel A, Wachowicz B. Long-term effects of whole body cryostimulation on uric acid concentration in plasma of secondary progressive multiple sclerosis patients. Scand J Clin Lab Invest 2013;73(8):635-40.

Zwolińska J, Kwolek A, Gąsior M. Skuteczność czynników fizykalnych wykorzystywanych w leczeniu osób ze stwardnieniem rozsianym. Przegląd piśmiennictwa. Post Rehab 2015;29(3):35-42.

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33(11):1444-52.

Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67(2):206-7.

Cohen JA, Krishnan AV, Goodman AD, Potts J, Wang P, Havrdova E, et al. The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis. JAMA Neurol 2014;71(11):1386-93. doi: 10.1001/jamaneurol.2014.1895.

Rymaszewska J, Pawik M. Czy krioterapia ogólnoustrojowa staje się formą terapii? Fam Med Primary Care Rev 2013;15(2):247-50.

Lubkowska A, Banfi G, Dołęgowska B, d’Eril GV, Łuczak J, Barassi A. Changes in lipid profile in response to three different protocols of whole-body cryostimulation treatments. Cryobiology 2010;61(1):22-6.

Lubkowska A, Szyguła Z, Klimek AJ, Torii M. Do sessions of cryostimulation have influence on white blood cell count, level of IL6 and total oxidative and antioxidative status in healthy men? Eur J Appl Physiol 2010;109(1):67-72.

Jonak A, Skrzek A. Krioterapia w odnowie biologicznej sportowców – przegląd badań. Acta Bio-Opt Inform Med 2009;15(4):319-21.

Stanek A, Sieroń A. Współczesna krioterapia ogólnoustrojowa w odnowie biologicznej. Ann Acad Med Siles 2012;66(4):64-70.

Rymaszewska J, Ramsey D, Chładzińska-Kiejna S, Kiejna A. Czy krótkotrwała ekspozycja na skrajnie niskie temperatury może być pomocna w leczeniu zaburzeń depresyjnych i lękowych? Psychiatr Pol 2007;41(5):625-36.

Szczepańska-Gieracha J, Borsuk P, Pawik M, Rymaszewska J. Mental state and quality of life after 10 session whole body cryotherapy. Psychol Health Med 2014;19(1):40-6.

Miller E. Kriostymulacja czynnikiem wspomagającym rehabilitację chorych na stwardnienie rozsiane z zespołem zmęczenia. Wiad Lek 2010;63(2):41-5.

Lamers I, Feys P. Upper limb function in patients with multiple sclerosis. Annals Physical Rehabilitation Med 2013;56(1):358-9.

Reis Rabelo PH, Pereira Botelho KK, Barbosa de Oliveira F. Grip strength after forearm cooling in healthy subjects. Fisioter Mov 2016;29(4):685-92.




DOI: https://doi.org/10.21164/pomjlifesci.633

Copyright (c) 2019 Anna Lubkowska, Aleksandra Radecka, Anna Knyszyńska, Joanna Łuczak

License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/